Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
42.59
-1.89 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,276 employees as of December 31, 2023. The number of employees decreased by 35 or -2.67% compared to the previous year.
Employees
1,276
Change (1Y)
-35
Growth (1Y)
-2.67%
Revenue / Employee
$439,052
Profits / Employee
-$446,068
Market Cap
3.94B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
RARE News
- 2 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update - GlobeNewsWire
- 15 days ago - Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update - GlobeNewsWire
- 17 days ago - Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS - GlobeNewsWire
- 5 weeks ago - Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside - Benzinga
- 5 weeks ago - Ultragenyx Reports Preliminary 2024 Revenue, Financial Guidance for 2025, Pipeline Updates, and 2025 Milestones - GlobeNewsWire
- 6 weeks ago - Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire